Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Chase William J. Director active across 2 companies, notably Intellia Therapeutics, Inc.. Aggregated, 18 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €861k. Activity tracked since 14 April 2023. The latest transaction was filed on 15 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Chase William J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
CHASE WILLIAM J is a declarant linked to GRAIL, Inc. and Intellia Therapeutics, Inc., where he is a director. His record includes 11 filings in total, and the sampled recent filings run from 2023-04-18 to 2026-06-22, with the transaction nature shown as Attribution.